The global Veterinary Antifibrotic Therapies market is poised for substantial growth in the coming years. According to Market Intelo's latest research, the market was valued at USD 1.42 billion in 2024 and is projected to grow at a CAGR of 7.6% from 2024 to 2032, reaching USD 2.69 billion by 2032. This growth is fueled by the increasing prevalence of fibrotic diseases in animals and the growing...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek